J.C. Romero, Congress, and passing the steroid buck

Leave a comment

I’ve been accused of being an apologist for players taking steroids. There’s an element of truth to that, I suppose, at least if you equate “not thinking that players who take PEDs are Satan” with being an apologist.  I simply think there are worse offenses in the baseball world, even if some folks disagree.

A big reason for my view of this is that not every player — and I’d argue not any player — who tests positive for PED is some cartoonish evil cheater with black intentions in their heart. Some are a little more brazen than others. Some, however, are just kind of screwed by circumstance.

Case in point: The Phillies’ J.C. Romero. As you’ll recall, he was suspended for 50 games to kick off the season as the result of testing positive for a steroid he took via an over the counter supplement last fall.  You’ll also recall that Romero has sued the supplement maker, claiming that it failed to identify the substances in the product that led to his positive test. That suit is still pending, but Major League Baseball — pursuant to a policy it implemented as the result of extreme Congressional heat — wasn’t all that interested in the details.

What gets lost in all of this is that neither Congress — the prime mover behind baseball’s current PED policy — and Major League Baseball — the enforcer — has clean hands in any of this.  Why? For one thing, Congress itself — with the help of President Clinton — was what allowed the current wild west supplement industry to blossom in the first place when it enacted the Dietary Supplement Health and Education Act of 1994, which basically punted all oversight of the supplement industry to . . . the supplement industry itself.  We should not have been shocked, therefore, when all manner of revolutionary products with all manner of questionable yet unnamed ingredients starting showing up at the GNC.

For its part, Major League Baseball famously lagged in telling the union that the supplement Romero was taking would lead to positive tests, even though it knew so ahead of time, and even though it had pledged to keep the union informed of the latest state of PEDs. Romero, in turn, relied on the union for his information.  Of course the union could have and should have told Romero that he needed to call the Major League Baseball hotline, where he could have gotten the updated information, but they failed to do that.

Upshot: there was a metric crap-ton of stuff that happened which led to Romero getting what amounted to a $1.5 million suspension, almost all of which was more the fault of those who would go after PED users than Romero himself.

Against that backdrop, today we learn that Congress is going to wade back into the fray and think about re-regulating the supplement world. That wading is led by Arlen Specter, who was spurred on, he says, by the Romero case. “We’re looking at whether there’s adequate protection for consumers from getting these supplements which have steroids or steroid-like substances,” Specter said.  Union head Don Fehr added that “players, like everyone else, have no idea what they’re taking.”  Specter is probably right to want to take another look at the supplement industry and review that 1994 deregulation. Fehr is right that players who take over the counter supplements may very well not know what they’e taking, partially due to MLB and the union not giving them good or timely information.

In light of this, it is an inescapable conclusion that the PED and supplement world is not comprised of a landscape in which there are cheaters and non-cheaters, evil and good. It’s a complicated environment, and that’s even before you get into the issue of certain things being legal in one country and not legal in another.

To the extent we as fans have decided otherwise and have adopted the rhetoric of good and evil in the great steroid debate, it’s because those congressional hearings and all that fell out of it set such a tone.  Now even Congress is reconsidering the matter.  Maybe we all should too.

Something big could be brewing between the Yankees, Mets and Marlins

Getty Images
3 Comments

Last night we heard the beginning of rumblings of a possible three-team trade involving the Yankees, Mets and Marlins that could involve J.T. Realmuto and Noah Syndergaard. Those rumblings — while still off in the distance — are getting a bit louder this morning, with reports floating that the Marlins are driving it and that it’s not just wishcasting from New York.

Into that mix comes something interesting: Ken Rosenthal reports that the Yankees are open to moving third baseman Miguel Andujar and that he’s “a name to watch.”

Coming as it does after that Yankees-Mets-Marlins chatter might mean that Andujar could be involved in all of that and, if he is, that could make for a monster deal.  Such a blockbuster would certainly be a good enough reason to part with Andujar despite a strong rookie season in which he hit.297/.328/.527 with 27 homers and 92 RBI. Worth noting that moving him could also open up third base for a big acquisition like Manny Machado, but that’s separate speculation, I suppose.

Not that any of this would be that easy, of course, especially if it involved the Mets. The Mets and Yankees rarely make trades with one another, and if they were to do one, it’d have to be something that the Mets could claim, convincingly, that they won lest they get raked over the tabloid coals. That being said, the Marlins reportedly want an established major leaguer in any deal for Realmuto and the Mets reportedly want more than just Realmuto if they were to give up Syndergaard. As such, Andujar could fit into that in any number of ways.

There’s obviously there’s a long way to go on this sort of thing, but the names floating around talks with the Yankees, Mets and Marlins are quite interesting and could suggest something big is brewing.